Natco Pharma rallied 3.83% to Rs 1,068.65 after the company’s consolidated net profit increased 40.07% to Rs 386.3 crore on 19.79% rise in total income to Rs 1,110.3 crore in Q4 FY24 over Q4 FY23.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
